The most important financial indicators for the company Dascalu Medical S.r.l. - Unique Identification Number 18340030:
sales in 2023 was
364.964
euro, registering a net profit of
122.103
euro and having an average number of
4
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 94.7%, from 188.045 euro in the year 2022, to 364.964 euro in 2023.
The Net Profit increased by 94.996 euro, from 27.190 euro in 2022, to 122.103 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Dascalu Medical S.r.l. - CUI 18340030
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
10.031
10.115
10.011
13.606
-
8.102
7.004
5.925
210.542
277.656
Current Assets
132.085
144.917
114.978
106.851
-
107.230
124.062
162.058
39.103
31.757
Inventories
0
0
900
0
-
0
0
0
0
0
Receivables
6
6.761
5.634
5.237
-
6.627
11.827
18.758
6.912
6.188
Cash
132.078
138.156
108.445
101.614
-
100.603
112.235
143.300
32.191
25.569
Shareholders Funds
127.500
152.831
98.628
97.881
-
113.461
129.557
166.591
96.965
191.666
Social Capital
223
225
223
219
-
211
207
202
203
202
Debts
14.616
2.201
26.362
22.576
-
1.870
1.509
1.392
152.681
42.446
Income in Advance
0
0
0
0
-
0
0
0
0
75.324
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
31.757 euro in 2023 which includes Inventories of
0 euro, Receivables of
6.188 euro and cash availability of
25.569 euro.
The company's Equity was valued at
191.666 euro, while total Liabilities amounted to
42.446 euro.
Equity increased by 94.996 euro, from 96.965 euro in 2022, to 191.666 in 2023.
The Debt Ratio was 13.7% in the year 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Dascalu Medical S.r.l.